We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
+$159M
Cap. Flow %
3.95%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAPT
351
DELISTED
RAPT Therapeutics
RAPT
$63.2K ﹤0.01%
+5,000
New +$63.5K
FE icon
352
PUT
FirstEnergy
FE
$27.5B
$59.8K ﹤0.01%
26,000
DTIL icon
353
Precision BioSciences
DTIL
$205M
$59.2K ﹤0.01%
15,534
+2,805
+22% +$20.5K
COO icon
354
PUT
Cooper Companies
COO
$14.4B
$55.8K ﹤0.01%
+12,000
New +$1.22M
XBI icon
355
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$55.5K ﹤0.01%
90,000
-45,000
-33% -$4.36M
IWM icon
356
CALL
iShares Russell 2000 ETF
IWM
$82.9B
$55.5K ﹤0.01%
45,000
-115,000
-72% -$26.2M
TGTX icon
357
CALL
TG Therapeutics
TGTX
$7.63B
$55K ﹤0.01%
40,000
+20,000
+100% +$574K
CAPR icon
358
CALL
Capricor Therapeutics
CAPR
$243M
$54K ﹤0.01%
+30,000
New +$526K
CCL icon
359
PUT
Carnival Corporation Ltd
CCL
$39.1B
$51.1K ﹤0.01%
500,000
-391,500
-44% -$9.16M
DYN icon
360
CALL
Dyne Therapeutics
DYN
$4.74B
$49K ﹤0.01%
+20,000
New +$592K
IRTC icon
361
CALL
iRhythm Holdings
IRTC
$4.29B
$44.5K ﹤0.01%
+15,000
New +$1.18M
IMCR icon
362
CALL
Immunocore
IMCR
$1.69B
$42.9K ﹤0.01%
+17,500
New +$553K
SYF icon
363
PUT
Synchrony
SYF
$25.5B
$42.2K ﹤0.01%
21,900
PRAX icon
364
CALL
Praxis Precision Medicines
PRAX
$9.91B
$41.8K ﹤0.01%
10,000
-3,000
-23% -$217K
XLV icon
365
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
$37.5K ﹤0.01%
+60,000
New +$8.78M
VERA icon
366
CALL
Vera Therapeutics
VERA
$2.32B
$36K ﹤0.01%
+15,000
New +$664K
AGEN
367
Agenus
AGEN
$301M
$35.3K ﹤0.01%
12,888
-10,000
-44% -$37K
QURE icon
368
CALL
uniQure
QURE
$3.2B
$31.6K ﹤0.01%
+115,000
New +$993K
KPTI icon
369
CALL
Karyopharm Therapeutics
KPTI
$45.1M
$30K ﹤0.01%
+26,667
New +$322K
RGNX icon
370
CALL
Regenxbio
RGNX
$690M
$30K ﹤0.01%
+80,000
New +$751K
CYH icon
371
CALL
Community Health Systems
CYH
$429M
$27K ﹤0.01%
+270,000
New +$1.13M
SNDX icon
372
PUT
Syndax Pharmaceuticals
SNDX
$1.79B
$25K ﹤0.01%
+100,000
New +$1.71M
BAX icon
373
CALL
Baxter International
BAX
$14.1B
$23.8K ﹤0.01%
+50,000
New +$1.68M
XAGEW
374
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$21.3K ﹤0.01%
371,250
INCY icon
375
CALL
Incyte
INCY
$24.4B
$19.5K ﹤0.01%
+20,000
New +$1.43M

Similar funds

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $159M of net new capital in Q4 2024, opening 130 new positions and adding to 130 existing holdings. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was US Steel, an estimated $62.2M trimmed.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.